Clinical Trials Logo
  1. Home
  2. Atrial Fibrillation New Onset
  3. NCT03523676

Use of Red Cell Distribution Width for Prediction of New-onset Atrial Fibrillation in Critically Ill Sepsis Patients

Atrial Fibrillation New Onset Clinical Trial

Official title:
Evaluation of Red Cell Distribution Width to Predict New-onset Atrial Fibrillation in Critically Ill Sepsis Patients

Clinical Trial Summary

Red cell distribution width variations are increased in a variety of medical conditions such as congestive heart failure, acute myocardial infarction, pulmonary embolism, pneumonia, critical illness, and cardiac arrest , and is a predictor of mortality in the general population..

Clinical Trial Description

This study was done retrospectively on sepsis patients admitted to intensive care units. data will be retrieved from patient medical records. The primay end point will be occurrence of new-onset AF during ICU stay. The secondary outcomes will be 28-day mortality.

The presence of anisocytosis or RDW variations has been classicaly used as a test for iron deficiency anemia. Increasing evidence points to its potential as a predictor for various conditions such as heart failure , malignancy, ischemic heart disease and sepsis.

Study investigators will examine the relationship between RDW levels and incidence of atrial fibrillation in critically ill sepsis patients as well as 28-day mortality. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03523676
Study type Observational
Source Ain Shams University
Contact
Status Completed
Phase
Start date January 1, 2017
Completion date March 10, 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06055751 - Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Completed NCT05818592 - Screening for Atrial Fibrillation With Self Pulse Monitoring N/A
Active, not recruiting NCT05780320 - A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting NCT03866148 - Obstructive Sleep Apnoea and Cardiac Arrhythmias N/A
Withdrawn NCT05656170 - Stellate Ganglion to Prevent Atrial Fibrillation N/A
Active, not recruiting NCT05255224 - PARADISE: Predicting AF After Cardiac Surgery
Recruiting NCT04528511 - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Recruiting NCT04857268 - Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120 N/A
Completed NCT04118270 - Shared Decision-Making: AFib 2gether Mobile App N/A
Active, not recruiting NCT03345615 - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation N/A
Not yet recruiting NCT05841056 - Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial Phase 3
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT03221777 - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting NCT03991754 - Prevention of New Onset AF After TAVI (PAF-TAVI Trial) Phase 3
Completed NCT03118518 - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation N/A
Completed NCT03552588 - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Recruiting NCT05444335 - Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years N/A
Terminated NCT05950971 - Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation N/A
Recruiting NCT05287191 - MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care Phase 3